Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TPM4 pseudogene 1 (TPM4P1) is a pseudogene related to the tropomyosin 4 (TPM4) gene[5]. Pseudogenes are genetic loci that resemble protein-coding genes but contain defects (such as premature stop codons or frameshifts) that prevent them from producing functional protein. There is no evidence that TPM4P1 is transcribed or translated into a functional molecule, and it is not considered a therapeutic target. The functional TPM4 gene encodes a tropomyosin isoform involved in actin filament regulation, muscle contraction, and various cellular processes, and is under investigation in cancer biology[1][2][3][6][8]; however, these properties do not extend to its pseudogenes such as TPM4P1. Summary: TPM4P1 is not a functional protein, enzyme, receptor, or classical molecular target. It is not involved in biological processes or disease mechanisms as an active entity, nor is it used as a biomarker or drug target. If you are interested in the functional tropomyosin 4 gene, the correct entry would be "Tropomyosin 4 (TPM4)" rather than "TPM4P1"[3][6][8].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TPM4 pseudogene 1 (TPM4P1).